Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.

Autor: Bicudo NP; Department of Medicine, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Germano CMR; Department of Medicine, Universidade Federal de São Carlos, São Carlos, SP, Brazil., de Moraes RT; Department of Medicine, Universidade Federal de São Carlos, São Carlos, SP, Brazil., de Avó LRDS; Department of Medicine, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Ferner RE; National Neurofibromatosis Service, Department of Neurology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Melo DG; Department of Medicine, Universidade Federal de São Carlos, São Carlos, SP, Brazil. Electronic address: dgmelo@ufscar.br.
Jazyk: angličtina
Zdroj: Anais brasileiros de dermatologia [An Bras Dermatol] 2024 Jul-Aug; Vol. 99 (4), pp. 520-526. Date of Electronic Publication: 2024 Mar 16.
DOI: 10.1016/j.abd.2023.08.011
Abstrakt: Background: Neurofibromatosis type 1 (NF1) is a rare genetic disorder with a wide range of clinical manifestations, notably neurocutaneous features, that can lead to emotional and physical consequences.
Objectives: This study assessed the influence of sociodemographic factors and clinical features of the disease on the quality of life of Brazilian individuals with NF1.
Methods: This is a descriptive cross-sectional study. Data were collected from 101 individuals with NF1 using the Brazilian version of the Impact of NF1 on Quality of Life Questionnaire (INF1-QoL), a form with information on sociodemographic characteristics, and an NF1 visibility self-evaluation scale. The relationship between variables was evaluated through statistical testing, and the significance level was defined as 0.05.
Results: The study included 101 adults with NF1 aged 18 to 59 years, with a mean age of 35.54 years (±9.63) and a female predominance (n = 84, 83.17%). The mean total INF1-QoL score was 10.62 (±5.63), with a median of 10, minimum value of 0, and maximum of 31 points. Two characteristics of the participants were significantly associated with the quality of life: educational level (p = 0.003) and familial history of NF1 (p = 0.019). There was a statistically significant correlation between the INF1-QoL score and the degree of disease visibility (rho = 0.218; p = 0.028).
Study Limitations: Cross-sectional study, conducted with a convenience sample and using self-reported measures.
Conclusions: The findings support the significant impact of NF1 on quality of life. The authors recommend multidisciplinary follow-up for patients, with adherence to anticipatory clinical care measures, adequate pain control, psychological assistance, and genetic counseling.
(Copyright © 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE